Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Yanking Their Capital Out Of Fluidigm Corporation (FLDM)

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only to high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ complex analysis to determine the best stocks to invest in. A particularly interesting group of stocks that hedge funds like is small-caps. The huge amount of capital does not allow hedge funds to invest a lot in small-caps, but our research showed that their most popular small-cap ideas are less efficiently priced and generate stronger returns than their large- and mega-cap picks and the broader market. That is why we follow the hedge fund activity in the small-cap space.

Most Advanced Countries in Medicine

everything possible/

Is Fluidigm Corporation (NASDAQ:FLDM) a buy, sell, or hold? Money managers are becoming less hopeful. The number of long hedge fund positions retreated by four recently. Fluidigm Corporation (NASDAQ:FLDM) was in 11 hedge funds’ portfolios at the end of the third quarter of 2015. There were 15 hedge funds in our database with Fluidigm Corporation (NASDAQ:FLDM) holdings at the end of the previous quarter. At the end of this article, we will also compare Fluidigm Corporation (NASDAQ:FLDM) to other stocks including Invivo Therapeutics Holdings Corp (NASDAQ:NVIV), Vectrus Inc (NYSE:VEC), and eHealth, Inc. (NASDAQ:EHTH) to get a better sense of its popularity.

Follow Fluidigm Corp (NASDAQ:FLDM)
Trade (NASDAQ:FLDM) Now!

To the average investor there are several formulas shareholders can use to grade their holdings. Some of the most underrated formulas are hedge fund and insider trading sentiment. Experts at Insider Monkey, a website specializing in hedge funds, have shown that, historically, those who follow the top picks of the top hedge fund managers can beat the broader indices by a healthy margin (see the details here).

With all of this in mind, we’re going to take a peek at the key action regarding Fluidigm Corporation (NASDAQ:FLDM).

Hedge fund activity in Fluidigm Corporation (NASDAQ:FLDM)

At Q3’s end, a total of 11 of the hedge funds tracked by Insider Monkey were long in this stock, a drop of 27% from the previous quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were upping their holdings significantly.

According to publicly available hedge fund holdings data compiled by Insider Monkey, Samuel Isaly’s OrbiMed Advisors has the most valuable position in Fluidigm Corporation (NASDAQ:FLDM), worth close to $19.9 million, comprising 0.2% of its total 13F portfolio. On OrbiMed Advisors’s heels is Scopia Capital, managed by Matt Sirovich and Jeremy Mindich, which holds a $10.6 million position; 0.2% of its 13F portfolio is allocated to the stock. Remaining members of the smart money with similar optimism contain Israel Englander’s Millennium Management, Hal Mintz’s Sabby Capital, and Ken Griffin’s Citadel Investment Group.

Seeing as Fluidigm Corporation (NASDAQ:FLDM) has experienced falling interest from the aggregate hedge fund industry, logic holds that there were a few hedgies that decided to sell off their positions entirely last quarter. Intriguingly, Phill Gross and Robert Atchinson’s Adage Capital Management said goodbye to the biggest stake of the 700 funds monitored by Insider Monkey, valued at close to $4.8 million in stock, and Andrew Sandler of Sandler Capital Management was right behind this move, as the fund said goodbye to about $3.1 million worth of shares. These transactions are intriguing to say the least, as total hedge fund interest dropped by four funds last quarter.

Let’s also examine hedge fund activity in other stocks similar to Fluidigm Corporation (NASDAQ:FLDM). These stocks are Invivo Therapeutics Holdings Corp (NASDAQ:NVIV), Vectrus Inc (NYSE:VEC), eHealth, Inc. (NASDAQ:EHTH), and OvaScience Inc (NASDAQ:OVAS). This group of stocks’ market valuations match Fluidigm Corporation (NASDAQ:FLDM)’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
NVIV 4 2559 2
VEC 10 11211 -2
EHTH 15 87458 3
OVAS 13 46912 -1

As you can see these stocks had an average of 10.5 hedge funds with bullish positions and the average amount invested in these stocks was $37 million. Investments in FLDM were much higher, with money managers that we track owning $56 million worth of its shares. eHealth, Inc. (NASDAQ:EHTH) is the most popular stock in this table. On the other hand Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) is the least popular one with only four bullish hedge fund positions. Fluidigm Corporation (NASDAQ:FLDM) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal, but because of the declining interest, we’d rather find a stock with better momentum. In this regard eHealth, Inc. (NASDAQ:EHTH) might be a better candidate to consider a long position in.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.